High expression of RAD21 predicts poor survival in patients with operated non-small-cell lung cancer.

CONCLUSION: High RAD21 expression indicates poor survival in patients with NSCLC. RAD21 may become a novel prognostic biomarker and therapeutic target in patients with NSCLC. PMID: 32178590 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research